Biomarkers predict brain tumour's response to therapy

A report in Cancer Research, a journal of the American Association for Cancer Research, highlights a new biomarker that may be useful in identifying patients with recurrent glioblastoma, or brain tumours, who would respond better to anti-vascular endothelial growth factor therapy, specifically cediranib...

Read the whole article on

More from